Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd. is a leading pharmaceutical company that develops and manufactures a broad range of pharmaceutical formulations and active pharmaceutical ingredients (APIs). Its primary function is to produce medicines in areas such as cardiology, psychiatry, neurology, gastroenterology, and diabetology, serving a global market. With a strong presence in the United States, India, and other international territories, the company provides both generic and specialty pharmaceuticals, thus significantly impacting the healthcare sectors it engages with. Established in 1983, Sun Pharma emphasizes research and development in order to deliver innovative therapeutic solutions. Its expansive product portfolio and robust distribution network allow it to play a critical role in enhancing healthcare accessibility worldwide. As a key player in the pharmaceutical industry, Sun Pharmaceutical Industries Ltd. is integral to pushing the boundaries of health and wellness through its commitment to quality and compliance. Its strategic acquisitions and partnerships further bolster its influence in the global pharmaceutical market.